EICHORCondition: Advanced Ovarian Cancer · Sponsor: Hospital Clinic of Barcelona
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The treatment of choice in advanced ovarian cancer is a cytoreductive surgery combined with chemotherapeutic treatment. This complex and aggressive surgery is associated with high postoperative complication rates that may result in a strong negative impact on the clinical results due to the delay with the start of adjuvant chemotherapy as well as the costs from the surgical process. Multimodal prehabilitation has emerged as an innovative intervention that focuses on optimizing physiological and psychological resilience to withstand the upcoming stress of surgery. It has been shown to reduce postoperative complications in major abdominal surgery, but has not been assessed yet in abdominal onco-gynecological surgery.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: 1. Patients with advanced ovarian cancer subject to primary debulking surgery or interval surgery after 3-4 cycles of chemotherapy or secondary and / or tertiary debulking surgery . 2. Patients with Eastern Cooperative Oncology Group (ECOG) performance status 2-0. 3. Adherence of at least 75 % of the program or minimum of 6 sessions. Exclusion Criteria: 1. Surgery without a minimum of 3 weeks of prehabilitation time. 2. Unstable respiratory or heart disease. 3. Locomotor or cognitive limitations that makes not feasible the adherence to the program. 4. Refusal of the patient.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Hospital Clinic Barcelona | Barcelona, Barcelona, Spain | — |
| Biomedical Research Institute la Fe | Valencia, Valencia, Spain | — |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04862325